Aims

For a prioritized set of rare movements disorders, we aim to:

  1. Secure trial-readiness, through natural history and biomarker discovery studies that provide sensitive and relevant outcome measures and inform the design of clinical trials;
  2. Identify new causes of rare movement disorders and implement these in diagnostic trajectories
  3. Generate new insights in molecular and system-level mechanisms, which serve as new disease markers or as leads for therapy;
  4. Design and test symptomatic and disease-modifying therapies. 


go to main content
Research Rare and genetic movement disorders

About

We conduct clinical and translational research on specific groups of rare movement disorders, with a focus on ataxias. Central themes are: identification of new (genetic) causes; trial readiness; understanding disease mechanisms; and testing symptomatic and disease-modifying interventions.

Research group leader

prof. dr. Bart van de Warrenburg

contact form

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more

Publications